Antiflautent
NDC Package 0603-0211-20

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Antiflautent is a . Marketed by Qualitest Pharmaceuticals, this product is identified by NDC 0603-0211 and is authorized under FDA application part332.

Identification & Billing

NDC Package Code
0603-0211-20
Package Description
60 TABLET, CHEWABLE in 1 BOTTLE
Product Code
11-Digit Billing Format
00603021120
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
60 EA

Clinical Specifications

Proprietary Name
Antiflautent
Dosage Form
-

Regulatory & Marketing

Labeler Name
Qualitest Pharmaceuticals
FDA Application #
part332
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
03-12-1999
End Marketing Date
05-26-2017
Listing Expiration
05-26-2017
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0603-0211-20 identifies a specific commercial package of 60 tablet, chewable in 1 bottle of Antiflautent, labeled by Qualitest Pharmaceuticals. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Qualitest Pharmaceuticals on March 12, 1999. The current certification is valid through May 26, 2017.

How is this Qualitest Pharmaceuticals product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00603021120. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0603-0211-20
11-Digit CMS (5-4-2)
00603-0211-20

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.